Back
Business
-
Briefly
BANGALORE: Advinus Therapeutics (P) Ltd. and Drugs for Neglected Diseases initiative (DNDi), a not-for-profit R&D organisation based in Geneva, Switzerland, announced on Thursday the formation of a collaboration for the discovery and development of novel therapies for visceral leishmaniasis (kala azar), a fatal infectious disease in developing countries, including India, says a release. — Staff Correspondent © Copyright 2000 - 2009 The Hindu |